Swiss National Bank Invests Heavily in MBX Biosciences

The Swiss National Bank has made a significant investment in MBX Biosciences, Inc. (NASDAQ:MBX), purchasing 44,400 shares valued at approximately $1.32 million during the first quarter of this year.

This purchase brings the bank's stake in the company to about 0.09% of its total shares outstanding. The Swiss National Bank is not alone in investing in MBX Biosciences, as several other hedge funds and institutional investors have also bought into the company recently.

Russell Investments Group Ltd. increased its stake by 4,131.4% during the third quarter and now owns 1,481 shares worth $26,000. Other notable investors include GF Fund Management CO. LTD., Strs Ohio, Royal Bank of Canada, and BNP Paribas Financial Markets.

The company's stock price has been on an upward trend, with a 50-day simple moving average of $48.63 and a 200-day simple moving average of $39.05. MBX Biosciences' market capitalization stands at around $3.14 billion, with a price-to-earnings ratio of -29.83 and a beta of 0.16.